Delivery Order SPE2DB22D3401-SPE2DB25FT0LH
Award Date
10/30/24
Potential Completion Date
10/31/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Gabapentin 800 mg tablets. The contract, valued at $2,016.96, is a Delivery Order issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of December 30, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 800 mg gabapentin tablets. The $3,227.98 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,114.86, is a Firm Fixed Price Delivery Order to provide 4,565,014,828 units of Gabapentin 300 mg capsules. The contract has a completion date of June 28, 2024 and was awarded on June 27, 2022. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of 500 tablets of 600 mg gabapentin, a prescription medication used to treat certain types of nerve pain. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on June 25, 2024. The contract has a ceiling value of $3,209.70 and a completion date of June 26, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,443.41 for the supply of the pharmaceutical product Gabapentin 800 mg tablets. The contract has a period of performance through March 20, 2024 and does not utilize any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,311.86, is for the delivery of 4,560,970,211 units of the pharmaceutical drug Gabapentin 800 mg tablets. The award has a completion date of May 18, 2023, and is structured as a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award is for the delivery of pharmaceutical products, specifically Gabapentin 600 mg tablets, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,166.10 and a completion date of March 2, 2022. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,702,489 units of gabapentin 300 mg capsules. The $1,349.23 firm-fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive...
This federal contract award SPE2DB22D1017|SPE2DB24FF8DX, valued at $1,734.73, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4564688627 - GABAPENTIN 300 MG CAPSULE 1000S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a performance period through May 23, 2024. The contract is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,507.38, is a Firm Fixed Price Delivery Order for the supply of Gabapentin 300 mg capsules. The contract has a period of performance through May 28, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans...